Imunon (NASDAQ:IMNN – Get Free Report) and Aridis Pharmaceuticals (NASDAQ:ARDS – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, risk, institutional ownership, dividends, analyst recommendations, valuation and earnings. Analyst Ratings This is a breakdown of current […]
Investment Analysts’ updated eps estimates for Monday, November 6th: Agronomics (LON:ANIC) had its buy rating reissued by analysts at Canaccord Genuity Group Inc.. They currently have a GBX 20 ($0.24) target price on the stock. Arcturus Therapeutics (NASDAQ:ARCT) had its outperform rating reaffirmed by analysts at William Blair. Aridis Pharmaceuticals (NASDAQ:ARDS) had its buy rating […]